Ticker RCUS – Arcus Biosciences – sales, description, marketcap – Tickerday.com

RCUS

Arcus Biosciences

Index: NYSE; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 1.13B; Volume: 429.25K; AvgVol 3m: 557.41K; Beta: ;

Cost estimate:

P/E: ; EPS: -2.44; EPS growth quarter/prev quarter: -44.70%;

EPS growth this year: -34.90%; EPS growth past 5 years: ;

EPS ttm: -2.44;

P/S: 78.00; P/B: 02.02; P/Cashflow: 2.53; P/FCF: ;

Sales: 15.00M; Sales growth quarter/prev quarter: 0.00%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -41.50%; ROE – return on equity: -49.10%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 13.70%; Insider Transactions:0.55%;

Institutional Ownership: 57.00%; Institutional Transactions: 66.50%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *